CoHort of Patients to Identify Biological and Imaging MarkerS of CardiovascUlar Outcomes in ST Elevation Myocardial Infarction

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral, Other, Biological
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

ST-segment elevation myocardial infarction (STEMI) is an acute condition that accounts for 75% of sudden deaths in adults over 35 years of age and more than half of all cases of chronic heart failure. However, the mechanism of myocardial infarction remains poorly understood. At present, there is no national information system for myocardial infarction, as there is for other diseases such as multiple sclerosis (OFSEP cohort). The purpose of this cohort is to enable studies and research projects to be carried out on the descriptive epidemiology of myocardial infarction, monitoring of patients undergoing treatment (safety, efficacy), quality of life and functional consequences of infarction, and research into new biological and imaging prognostic biomarkers. Its general objective is to provide researchers, hospital practitioners, medical interns, academics or industrialists with a quality epidemiological tool for research.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥ 18 years

• Diagnosis of STEMI defined by ST segment elevation ≥ 0.2 mV in 2 contiguous leads on a 12-lead ECG.

• Management in primary ACT

• Prior oral informed consent followed by signed informed consent as soon as possible.

Locations
Other Locations
France
Hospices Civils de Lyon - Hôpital Louis Pradel
RECRUITING
Bron
Hospices Civils de Lyon - Hôpital de la Croix Rousse
RECRUITING
Lyon
Contact Information
Primary
Thomas BOCHATON, Dr
thomas.bochaton@chu-lyon.fr
04 72 35 75 41
Backup
Yvonne VARILLON
yvonne.varillon@chu-lyon.fr
04 72 35 69 64
Time Frame
Start Date: 2023-05-03
Estimated Completion Date: 2031-06-03
Participants
Target number of participants: 300
Treatments
Other: Cohort group
patient with ST-segment elevation myocardial infarction.
Sponsors
Leads: Hospices Civils de Lyon

This content was sourced from clinicaltrials.gov